These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19278731

  • 1. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G.
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [Abstract] [Full Text] [Related]

  • 2. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G, Siwek M, Dudek D, Zieba A, Pilc A.
    Pol J Pharmacol; 2003 Nov; 55(6):1143-7. PubMed ID: 14730113
    [Abstract] [Full Text] [Related]

  • 3. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
    Rogóz Z, Skuza G, Wójcikowski J, Daniel WA, Wróbel A, Dudek D, Zieba A.
    Pol J Pharmacol; 2004 Nov; 56(6):849-55. PubMed ID: 15662100
    [Abstract] [Full Text] [Related]

  • 4. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment.
    Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zieba A, Pilc A, Popik P, Nowak G.
    J Affect Disord; 2010 Nov; 126(3):447-52. PubMed ID: 20493532
    [Abstract] [Full Text] [Related]

  • 5. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z, Dziedzicka-Wasylewska M, Daniel WA, Wójcikowski J, Dudek D, Wróbel A, Zieba A.
    Pol J Pharmacol; 2004 Nov; 56(6):735-42. PubMed ID: 15662086
    [Abstract] [Full Text] [Related]

  • 6. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC.
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [Abstract] [Full Text] [Related]

  • 7. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C, Baghai TC, Eser D, Nothdurfter C, Rupprecht R.
    World J Biol Psychiatry; 2009 Dec; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [Abstract] [Full Text] [Related]

  • 8. Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression.
    Prasko J, Horacek J, Klaschka J, Kosova J, Ondrackova I, Sipek J.
    Neuro Endocrinol Lett; 2002 Apr; 23(2):109-13. PubMed ID: 12011795
    [Abstract] [Full Text] [Related]

  • 9. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
    Heresco-Levy U, Javitt DC, Gelfin Y, Gorelik E, Bar M, Blanaru M, Kremer I.
    J Affect Disord; 2006 Jul; 93(1-3):239-43. PubMed ID: 16677714
    [Abstract] [Full Text] [Related]

  • 10. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP, Galinowski A, Lehert P, Lemonnier F, Lôo H.
    Encephale; 1993 Jul; 19(4):333-40. PubMed ID: 8275921
    [Abstract] [Full Text] [Related]

  • 11. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L.
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [Abstract] [Full Text] [Related]

  • 12. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal.
    Bernstein GA, Borchardt CM, Perwien AR, Crosby RD, Kushner MG, Thuras PD, Last CG.
    J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):276-83. PubMed ID: 10714046
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
    Sato Y, Yasui-Furukori N, Nakagami T, Saito M, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr 30; 33(3):416-8. PubMed ID: 19166896
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
    Lopez-Ibor JJ, Conesa A, Spanish Milnacipran/Imipramine Study.
    Curr Med Res Opin; 2004 Jun 30; 20(6):855-60. PubMed ID: 15200743
    [Abstract] [Full Text] [Related]

  • 15. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M, Kopecek M, Novak T, Stopkova P, Sos P, Kozeny J, Brunovsky M, Höschl C.
    J Affect Disord; 2009 Nov 30; 118(1-3):94-100. PubMed ID: 19249105
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul 30; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD, Kundhur D, Solomons K, Yatham LN, Lam RW.
    J Psychiatry Neurosci; 2003 Jan 30; 28(1):55-9. PubMed ID: 12587851
    [Abstract] [Full Text] [Related]

  • 18. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study.
    Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB, Gastfriend DR.
    J Clin Psychopharmacol; 1988 Apr 30; 8(2):120-4. PubMed ID: 3131389
    [Abstract] [Full Text] [Related]

  • 19. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG, Lunde M, Lindberg L, Undén M, Dissing S, Bech P.
    Pharmacopsychiatry; 2008 Mar 30; 41(2):41-7. PubMed ID: 18311683
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK.
    Arch Gen Psychiatry; 2006 Aug 30; 63(8):856-64. PubMed ID: 16894061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.